Case Report (n=1)
Highlights the importance of recognizing cholesterol-embolisation syndrome as a rare but severe complication following invasive endovascular procedures like coronary stenting.
Answers are grounded in this paper and cite their sources.
Retiform rash with purplish toes may signal CES in atherosclerotic patients; leaves open validation in prospective cohorts.
Cholesterol-embolisation syndrome presenting as retiform rash and purplish toesDear Editor, Cholesterol-embolisation syndrome (CES) is a systemic disease due to dislodgement of atherosclerotic plaque materials, such as cholesterol crystals, from the aorta and its major branches to the distal circulation, causing ischaemic and inflammatory injury to multiple organs.
No takes yet. Share an insight, caveat, or question.
Meena et al. (2024) conducted a case report in Cholesterol-embolisation syndrome (n=1). Coronary stenting was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: